Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto, Canada. Dr. McIntyre was named by Clarivate Analytics in 2014, 2015, 2016, 2017, 2018, 2019 and 2020 as one of “The World’s Most Influential Scientific Minds”. This...
KetaMD Expands Access to Breakthrough Ketamine Therapy in Florida to Battle the Growing Mental Health Crisis and Shortage of Mental Health Care Providers
Braxia Scientific Corp, (CSE: BRAX | OTC: BRAXF | FWB: 4960) a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments...
Oct 04, 2022
Last updated: Aug 12, 2022